FDA, Moderna and Flu Vaccine
Digest more
FDA issues a surprise refusal to review Moderna's mRNA-based flu vaccine filing, despite earlier agreement on trial design. Decision is described as unprecedented, with no cited safety or efficacy concerns in the application.
SAN FRANCISCO -- Moderna announced people may need a second booster to increase protection. But is a fourth shot the right approach? ABC7 News reporter Luz Pena from San Francisco spoke to multiple Bay Area experts, who say a second booster won't be ...